Seres Therapeutics's market cap is currently $138.57M. The company's EPS TTM is $-1.19; its P/E ratio is ―; Seres Therapeutics is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is $-0.20. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 126.33M	$ 7.13M	$ 144.93M	$ 33.22M	$ 34.51M
Gross Profit	$ 125.62M	$ 6.12M	$ 143.19M	$ -57.35M	$ -45.64M
Operating Income	$ -107.98M	$ -246.49M	$ -64.49M	$ -88.13M	$ -71.88M
EBITDA	$ -94.31M	$ -237.51M	$ -56.72M	$ -77.31M	$ -59.95M
Net Income	$ -113.72M	$ -253.82M	$ -61.50M	$ -86.45M	$ -64.24M
Balance Sheet
Cash & Short-Term Investments	$ 127.97M	$ 181.34M	$ 290.71M	$ 253.62M	$ 94.82M
Total Assets	$ 358.60M	$ 348.78M	$ 354.86M	$ 342.94M	$ 132.44M
Total Debt	$ 213.94M	$ 162.59M	$ 49.21M	$ 40.77M	$ 44.78M
Net Debt	$ 85.97M	$ -440.00K	$ -130.79M	$ -75.28M	$ -20.35M
Total Liabilities	$ 403.46M	$ 338.00M	$ 223.35M	$ 168.19M	$ 180.76M
Stockholders' Equity	$ -44.86M	$ 10.78M	$ 131.51M	$ 174.75M	$ -48.32M
Cash Flow
Free Cash Flow	$ -125.33M	$ -238.64M	$ -2.88M	$ -94.20M	$ -77.52M
Operating Cash Flow	$ -117.35M	$ -228.82M	$ 6.69M	$ -93.61M	$ -76.52M
Investing Cash Flow	$ 10.58M	$ 82.43M	$ 64.09M	$ -158.89M	$ -30.52M
Financing Cash Flow	$ 71.70M	$ 129.60M	$ 1.18M	$ 303.42M	$ 86.23M

Currency in USD

Seres Therapeutics Earnings and Revenue History

Income Statement >

Seres Therapeutics Debt to Assets

Balance Sheet >

Seres Therapeutics Cash Flow

Cash Flow >

Seres Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing